Safety and efficacy of ticlopidine after stent placement.
Henry
P
P
Service de Cardiologie, H¿opital Broussais, H¿optial Lariboisiere, Paris, France.
Beverelli
F
F
D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D003327:Coronary Disease / Q000628:therapy; D003331:Coronary Vessels / Q000000981:diagnostic imaging; D004334:Drug Administration Schedule; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D015607:Stents / Q000009:adverse effects; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control; D013988:Ticlopidine / Q000008:administration & dosage*; D018084:Ultrasonography, Interventional
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine; D000077284:Abciximab